Fundz Deep Dive
Everything you need to win Sanofi — in one platform.
Who to reach, what to say, and why now on Sanofi — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.
Get the full Deep Dive on Sanofi — free.
One free Deep Dive, emailed to you. No spam; unsubscribe anytime.
Ready now? Choose your plan · Request a demo · Sign in
Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.
Sanofi India Limited and Emcure Announce Exclusive Distribution Partnership for Oral Anti-Diabetic Drugs
Jul 17, 2025•11 months ago
Contract Type
partnership
ParisBiotechnologyHealth CareMedicalPharmaceuticalDescription
Sanofi India Limited has formed an exclusive distribution partnership with Emcure to enhance access to oral anti-diabetic medications. This collaboration aims to broaden the reach of these important therapeutic products in the market.
Related People
Suggested for you
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months